Mesoblast (MESO) Interest Coverage Ratio (2014 - 2023)
Mesoblast (MESO) posted quarterly Interest Coverage Ratio of 0.39 for Q2 2023, up 8420.37% year-on-year from 0.0 in Q2 2022, and up 303.5% on a QoQ basis from 0.19 in Q1 2023.
Mesoblast (MESO) Interest Coverage Ratio (2014 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Interest Coverage Ratio for 10 consecutive years, with 0.39 the latest figure, recorded in Q2 2023.
- Quarterly Interest Coverage Ratio rose 8420.37% year-over-year to 0.39 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.27 (up 91.02% YoY) and the FY2025 annual result came in at 2.7, down 5.72% from the prior year.
- Interest Coverage Ratio grew to 0.39 in Q2 2023 per MESO's latest filing, from 0.19 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for MESO reached as high as 20.12 in Q2 2021 and fell as low as 7.64 in Q1 2019.
- A 5-year average of 0.6 and a median of 1.19 in 2019 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2020 — Interest Coverage Ratio plunged 406.65% — and 2023, when it jumped 8420.37%.
- Year by year, Interest Coverage Ratio stood at 6.46 in 2019, then gained by 16.13% to 5.41 in 2020, then surged by 207.82% to 5.84 in 2021, then slumped by 122.24% to 1.3 in 2022, then soared by 129.77% to 0.39 in 2023.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.39, 0.19, and 1.3 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -1.30 |
| Sep 30, 2022 | -2.72 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | 5.84 |
| Sep 30, 2021 | -4.48 |
| Jun 30, 2021 | 20.12 |
| Mar 31, 2021 | -5.74 |
| Dec 31, 2020 | -5.41 |
| Sep 30, 2020 | -5.44 |
| Jun 30, 2020 | -0.46 |
| Mar 31, 2020 | -3.61 |
| Dec 31, 2019 | -6.46 |
| Sep 30, 2019 | -1.07 |
| Jun 30, 2019 | 7.99 |
| Mar 31, 2019 | -7.64 |
| Dec 31, 2018 | 12.05 |
| Sep 30, 2018 | 8.62 |